ARTICLE | Financial News
NovaBay planning follow-on
December 6, 2012 2:14 AM UTC
NovaBay Pharmaceuticals Inc. (NYSE-M:NBY) said late Wednesday it is planning a follow-on underwritten by Lazard. NovaBay was off $0.06 to $1.39 on the day. ...
NovaBay Pharmaceuticals Inc. (NYSE-M:NBY) said late Wednesday it is planning a follow-on underwritten by Lazard. NovaBay was off $0.06 to $1.39 on the day. ...